This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Sep;19(9):928.

doi: 10.1016/S1473-3099(19)30430-X.

Phase 3 trial of treating gonorrhoea with solithromycin

Prabhavathi Fernandes¹, J Carl Craft²

Affiliations

PMID: 31478511
DOI: 10.1016/S1473-3099(19)30430-X

Comment

Phase 3 trial of treating gonorrhoea with solithromycin

Prabhavathi Fernandes et al. Lancet Infect Dis. 2019 Sep.

. 2019 Sep;19(9):928.

doi: 10.1016/S1473-3099(19)30430-X.

Authors

Prabhavathi Fernandes¹, J Carl Craft²

Affiliations

¹ Chapel Hill, NC 27514, USA. Electronic address: prabha.fernandes@gmail.com.
² Libertyville, IL, USA.

PMID: 31478511
DOI: 10.1016/S1473-3099(19)30430-X

No abstract available

PubMed Disclaimer

Comment on

Solithromycin versus ceftriaxone plus azithromycin for the treatment of uncomplicated genital gonorrhoea (SOLITAIRE-U): a randomised phase 3 non-inferiority trial.
Chen MY, McNulty A, Avery A, Whiley D, Tabrizi SN, Hardy D, Das AF, Nenninger A, Fairley CK, Hocking JS, Bradshaw CS, Donovan B, Howden BP, Oldach D; Solitaire-U Team. Chen MY, et al. Lancet Infect Dis. 2019 Aug;19(8):833-842. doi: 10.1016/S1473-3099(19)30116-1. Epub 2019 Jun 10. Lancet Infect Dis. 2019. PMID: 31196813 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information